Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

The variety of potentially useful dyes or haptenes available for fluorescent nucleic acid hybridization assays is far greater than what can be obtained from commercial sources 1,2. Since this ...

Scientists at The Wistar Institute have discovered how a key protein from the Epstein-Barr virus (EBV), EBNA-LP, ...

When the Empire State Building was constructed, its 102 stories rose above midtown one piece at a time, with each individual ...

Astute Analytica stands out as a premier provider of comprehensive Japan Point-of-Care Testing market research reports specifically tailored for the healthcare sector. Our commitment lies in ...

In April of that year, patients started appearing at hospitals in the industrial city of Sverdlovsk, now known as ...

Isothermal nucleic acid amplification technology market was valued at US$ 6.06 billion in 2024 and is projected to hit the market valuation of US$ 17.26 billion by 2033 at a CAGR of 12.34% during the ...

No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.

Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...

The global Oligonucleotide Synthesis Market is valued at USD 7.78 Billion in 2024 and is projected to reach a value of USD 21 ...

German CDMO BioSpring is building a new production facility that it hopes will become one of the world's biggest ...